Tatva Chintan Q1 PAT doubles; board clears Rs 200 Cr Dahej expansion
TATVA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 19.2 pts more than Nifty Microcap 250 and 19.5 pts more than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Consolidated revenue up 25% YoY to Rs 1,670 million; PAT doubled to Rs 160 million. Standalone revenue grew 34% to Rs 1,467 million, PAT at Rs 104 million. Board approved Dahej-III greenfield unit with 344 KL reactor capacity, Rs 200 Cr investment over 21 months. Borrowing limit proposed to rise from Rs 300 Cr to Rs 1,000 Cr. Re-appointed Managing Director and two whole-time directors for 3 years. Statutory auditors gave unmodified review opinion.
Strong Q1 earnings growth signals recovery; capacity expansion shows growth intent but 3x jump in debt limit may raise concerns.